DexCom ROA 2006-2018 | DXCM

Current and historical return on assets (ROA) values for DexCom (DXCM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. DexCom ROA for the three months ending September 30, 2018 was -1.39%.
DexCom ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.04B $1.11B 4.49%
2018-06-30 $-0.01B $1.01B -0.55%
2018-03-31 $-0.03B $0.90B -3.72%
2017-12-31 $-0.05B $0.90B -6.64%
2017-09-30 $-0.05B $0.84B -7.65%
2017-06-30 $-0.07B $0.80B -12.82%
2017-03-31 $-0.09B $0.47B -22.49%
2016-12-31 $-0.07B $0.40B -18.61%
2016-09-30 $-0.06B $0.36B -17.42%
2016-06-30 $-0.08B $0.33B -27.10%
2016-03-31 $-0.06B $0.30B -24.02%
2015-12-31 $-0.06B $0.29B -24.27%
2015-09-30 $-0.06B $0.26B -27.80%
2015-06-30 $-0.02B $0.22B -11.19%
2015-03-31 $-0.02B $0.19B -13.67%
2014-12-31 $-0.02B $0.19B -15.11%
2014-09-30 $-0.03B $0.16B -19.74%
2014-06-30 $-0.03B $0.14B -22.49%
2014-03-31 $-0.03B $0.13B -27.83%
2013-12-31 $-0.03B $0.12B -27.65%
2013-09-30 $-0.04B $0.11B -33.57%
2013-06-30 $-0.05B $0.10B -44.88%
2013-03-31 $-0.05B $0.10B -48.69%
2012-12-31 $-0.05B $0.11B -49.32%
2012-09-30 $-0.06B $0.10B -51.21%
2012-06-30 $-0.05B $0.11B -45.09%
2012-03-31 $-0.05B $0.12B -36.51%
2011-12-31 $-0.04B $0.12B -38.85%
2011-09-30 $-0.04B $0.13B -41.08%
2011-06-30 $-0.04B $0.14B -50.30%
2011-03-31 $-0.05B $0.07B -72.59%
2010-12-31 $-0.06B $0.08B -84.62%
2010-09-30 $-0.06B $0.05B -99.13%
2010-06-30 $-0.06B $0.06B -100.87%
2010-03-31 $-0.06B $0.07B -104.27%
2009-12-31 $-0.05B $0.05B -88.52%
2009-09-30 $-0.06B $0.05B -92.95%
2009-06-30 $-0.06B $0.07B -100.87%
2009-03-31 $-0.06B $0.08B -104.50%
2008-12-31 $-0.06B $0.04B -110.80%
2008-09-30 $-0.06B $0.04B -97.56%
2008-06-30 $-0.06B $0.06B -76.39%
2008-03-31 $-0.05B $0.07B -62.20%
2007-12-31 $-0.05B $0.08B -52.75%
2007-09-30 $-0.04B $0.09B -50.00%
2007-06-30 $-0.05B $0.10B -53.64%
2007-03-31 $-0.05B $0.11B -55.59%
2006-12-31 $-0.05B $0.07B -67.40%
2006-09-30 $-0.05B $0.08B -70.94%
2006-06-30 $-0.04B $0.09B -63.24%
2006-03-31 $-0.04B $0.05B -58.82%
2005-12-31 $-0.03B $0.06B -55.56%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.682B $0.719B
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.622B 22.05
Intuitive Surgical (ISRG) United States $57.410B 56.48
Edwards Lifesciences (EW) United States $31.251B 33.44
Fresenius Medical Care AG KGaA (FMS) Germany $20.890B 14.12
IDEXX Laboratories (IDXX) United States $16.366B 46.75
ABIOMED (ABMD) United States $14.199B 102.02
Hologic (HOLX) United States $12.300B 18.99
Teleflex (TFX) United States $11.493B 26.09
Varian Medical Systems (VAR) United States $11.273B 28.05
STERIS (STE) United Kingdom $9.112B 24.18
Masimo (MASI) United States $5.899B 38.25
Penumbra (PEN) United States $4.402B 265.81
LivaNova (LIVN) United Kingdom $4.351B 27.93
Globus Medical (GMED) United States $4.081B 25.58
Integra LifeSciences Holdings (IART) United States $3.806B 18.54
Wright Medical Group (WMGI) Netherlands $3.486B 0.00
Cantel Medical (CMD) United States $3.238B 31.94
Inogen (INGN) United States $2.983B 64.38
Integer Holdings (ITGR) United States $2.502B 20.94
Tandem Diabetes Care (TNDM) United States $2.365B 0.00
OPKO Health (OPK) United States $2.071B 0.00
Halyard Health (AVNS) United States $2.027B 18.26
Glaukos (GKOS) United States $2.006B 0.00
Nevro (NVRO) United States $1.167B 0.00
Natus Medical (BABY) United States $1.131B 23.76
Tactile Systems Technology (TCMD) United States $1.115B 177.59
Luminex (LMNX) United States $1.106B 40.03
Pacific Biosciences Of California (PACB) United States $1.079B 0.00
CryoLife (CRY) United States $0.993B 86.64
Orthofix (OFIX) United States $0.927B 26.79
Intersect ENT (XENT) United States $0.824B 0.00
Accelerate Diagnostics (AXDX) United States $0.822B 0.00
Mesa Laboratories (MLAB) United States $0.817B 48.31
AngioDynamics (ANGO) United States $0.753B 24.42
ViewRay (VRAY) United States $0.651B 0.00
Veracyte (VCYT) United States $0.641B 0.00
AxoGen (AXGN) United States $0.614B 0.00
TransEnterix (TRXC) United States $0.575B 0.00
Si-Bone (SIBN) United States $0.520B 0.00
OrthoPediatrics (KIDS) United States $0.410B 0.00
Sientra (SIEN) United States $0.394B 0.00
Quotient (QTNT) Switzerland $0.392B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.388B 0.00
Accuray (ARAY) United States $0.341B 0.00
Fluidigm (FLDM) United States $0.339B 0.00
GenMark Diagnostics (GNMK) United States $0.337B 0.00
IRadimed (IRMD) United States $0.289B 75.51
Neuronetics (STIM) United States $0.277B 0.00
SeaSpine Holdings (SPNE) United States $0.269B 0.00
Nuvectra (NVTR) United States $0.254B 0.00
RTI Surgical (RTIX) United States $0.253B 39.80
Pulse Biosciences (PLSE) United States $0.247B 0.00
CRH Medical (CRHM) Canada $0.225B 38.75
Corindus Vascular Robotics (CVRS) United States $0.218B 0.00
Helius Medical Technologies (HSDT) United States $0.209B 0.00
T2 Biosystems (TTOO) United States $0.163B 0.00
Sensus Healthcare (SRTS) United States $0.129B 0.00
Ra Medical Systems (RMED) United States $0.123B 0.00
Ekso Bionics Holdings (EKSO) United States $0.098B 0.00
Alphatec Holdings (ATEC) United States $0.080B 0.00
EDAP TMS (EDAP) France $0.073B 0.00
Biosig Technologies (BSGM) United States $0.071B 0.00
Second Sight Medical Products (EYES) United States $0.069B 0.00
Apollo Endosurgery (APEN) United States $0.067B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.066B 0.00
OBALON THERPTCS (OBLN) United States $0.044B 0.00
Vermillion (VRML) United States $0.042B 0.00
Electromed (ELMD) United States $0.042B 19.96
Viveve Medical (VIVE) United States $0.040B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
Restoration Robotics (HAIR) United States $0.033B 0.00
Titan Medical (TMDI) Canada $0.031B 0.00
Xtant Medical Holdings (XTNT) United States $0.030B 0.00
Microbot Medical (MBOT) United States $0.029B 0.00
PAVmed (PAVM) United States $0.025B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.025B 0.00
Lianluo Smart (LLIT) China $0.023B 0.00
Dynatronics (DYNT) United States $0.022B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
Neovasc (NVCN) Canada $0.014B 0.00
American Shared Hospital Services (AMS) United States $0.014B 10.44
Bioanalytical Systems (BASI) United States $0.013B 64.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Presbia (LENS) Ireland $0.010B 0.00
Avinger (AVGR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
Amedica (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00